強生三季度業績超出預期,並上調了全年調整後每股收益指引。週二盤前交易中,JNJ股價下跌1.4%,此前業績基本符合預期。中東衝突拖累了本季度強生醫療器械的銷售。來源J&J beats earnings estimates; Middle East conflict weighs on medical device salesReutersJ&J falls premarket despite raised earnings guidanceSeekingalpha